1492 Capital Management’s CareDx CDNA Stock Holding History

1492 Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$357K	Hold	12,534	–	–	0.11%	105
2026 Q1	$218K	Buy	+12,534	New	+$237K	0.08%	124

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

1492 Capital Management's CDNA Position: Q2 2026 in Review

1492 Capital Management held its CareDx (CDNA) position steady in Q2 2026 at 12,534 shares worth $357K. The position accounts for 0.11% of the portfolio, ranked #105.

1492 Capital Management first reported a position in CDNA in Q1 2026 and has held it in 2 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

1492 Capital Management held 12,534 shares of CareDx worth $357K as of Q2 2026.
1492 Capital Management left its CareDx share count unchanged in Q2 2026.
CareDx made up 0.11% of 1492 Capital Management's portfolio in Q2 2026, its #105 holding.
1492 Capital Management first reported a position in CareDx in Q1 2026 and has held it in 2 quarters since.
227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on 1492 Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.